In December 2024, Zepbound received FDA approval as the first medication ever indicated for moderate-to-severe obstructive sleep apnea in adults with obesity
Stick to the recommended dosage
In another study, intraperitoneal administration of BPC-157 (2ug/kg) improved motor function, reduced lesions in white and grey matter and relieved neuronal damage in rats with spinal cord injury [5] Research in the alkali burn rat models has shown that topical BPC-157 can speed up wound closure
Nuche-Berenguer B, Moreno P, Esbrit P, Dapa S, Caeiro JR, Cancelas J, et al
Photobiomodulation has been shown to enhance mitochondrial activity, improve tissue repair, and support collagen production (Hamblin, 2021)
Thats especially relevant with GLP-1 medications, which can promote fairly rapid fat loss